Co-diagnostics, inc. jv cosara diagnostics recognized for work combating covid-19 surge in india

Salt lake city, april 28, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its indian manufacturing facility, cosara diagnostics pvt. ltd. ("cosara," or the "jv", a joint venture with synbiotics ltd) has been featured in recent press highlighting its actions to provide much-needed covid-19 diagnostics as a wave of infections has led to the world's worst covid-19 outbreak since the pandemic began.
CODX Ratings Summary
CODX Quant Ranking